During the past decade, Port Macquarie Base Hospital;North Coast Cancer Institute conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Port Macquarie Base Hospital;North Coast Cancer Institute" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Australasian Gastro-Intestinal Trials Group" with 1 trials as a collaborator, "INDOX Cancer Research Network" with 1 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator and "University of Oxford" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Port Macquarie Base Hospital;North Coast Cancer Institute" are "Colorectal Cancer" (2 trials), "Breast Cancer" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Port Macquarie Base Hospital;North Coast Cancer Institute" in a lesser frequency.

Most popular intervention types in "Port Macquarie Base Hospital;North Coast Cancer Institute" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abiraterone" (1 trials), "Acetylsalicylic acid" (1 trials), "Atezolizumab (MPDL3280A), an Engineered Anti-PDL1 Antibody" (1 trials), "Cobimetinib" (1 trials) and "Enzalutamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Port Macquarie Base Hospital;North Coast Cancer Institute" are 2 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Port Macquarie Base Hospital;North Coast Cancer Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Port Macquarie Base Hospital;North Coast Cancer Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Port Macquarie Base Hospital;North Coast Cancer Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".